Skip to main navigation Skip to search Skip to main content

IRI-EXPLORE: Randomised study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in Patient

Project: Research

Project Details

StatusActive
Effective start/end date11/1/24 → 11/1/26

Funding

  • Boehringer Ingelheim Pharmaceutical: $2.00